Can-Fite BioPharma Ltd. (CANF) Stock Price History
Historical prices from 2012 to 2026
Loading 10-year price history...
Historical Performance
Short-Term Returns
CANF Stock Price Trajectory (2012–2026)
As of March 1, 2026, Can-Fite BioPharma Ltd. (CANF) trades at $4.75, representing a +169.9% return over the past year. The stock has delivered a -25.1% return over five years, reflecting challenging market conditions.
The stock reached its all-time high of $1,419.00 on December 23, 2013. From this peak, CANF has corrected -99.7%, currently trading 244% above its 200-day moving average, indicating continued institutional support.
When compared to Healthcare sector peers ARGX (+22.8% 1Y), AKTX (-72.9% 1Y), and ABVX (+1479.2% 1Y), CANF has underperformed the peer group average. Compare CANF vs ARGX →
Historical Price Data
Showing 30 of 3,348 records| Date | Open | High | Low | Close | Volume | Change % |
|---|---|---|---|---|---|---|
| 2026-02-27 | 4.84 | 4.89 | 4.64 | 4.75 | 4 | -3.65% |
| 2026-02-26 | 4.49 | 4.93 | 4.43 | 4.93 | 4 | +7.41% |
| 2026-02-25 | 4.38 | 4.60 | 4.21 | 4.59 | 4 | +4.56% |
| 2026-02-24 | 4.55 | 4.65 | 4.39 | 4.39 | 4 | -1.35% |
| 2026-02-23 | 4.65 | 4.65 | 4.36 | 4.45 | 4 | -4.30% |
| 2026-02-20 | 4.45 | 4.65 | 4.29 | 4.65 | 4 | +4.73% |
| 2026-02-19 | 4.30 | 4.44 | 4.29 | 4.44 | 12K | +3.02% |
| 2026-02-18 | 4.39 | 4.41 | 4.21 | 4.31 | 11K | -0.46% |
| 2026-02-17 | 4.25 | 4.46 | 4.25 | 4.33 | 19K | -4.41% |
| 2026-02-13 | 4.25 | 4.59 | 4.12 | 4.53 | 40K | +4.86% |
| 2026-02-12 | 4.26 | 4.40 | 4.12 | 4.32 | 9K | -1.82% |
| 2026-02-11 | 4.40 | 4.44 | 4.23 | 4.40 | 8K | +1.38% |
| 2026-02-10 | 4.36 | 4.74 | 4.22 | 4.34 | 45K | +2.84% |
| 2026-02-09 | 4.20 | 4.31 | 4.17 | 4.22 | 38K | +1.44% |
| 2026-02-06 | 4.18 | 4.42 | 4.02 | 4.16 | 56K | -2.12% |
| 2026-02-05 | 4.10 | 4.50 | 4.10 | 4.25 | 523K | +5.20% |
| 2026-02-04 | 4.25 | 4.27 | 4.04 | 4.04 | 16K | -0.25% |
| 2026-02-03 | 4.13 | 4.17 | 4.00 | 4.05 | 22K | -1.94% |
| 2026-02-02 | 4.16 | 4.32 | 4.05 | 4.13 | 24K | +2.99% |
| 2026-01-30 | 4.00 | 4.18 | 4.00 | 4.01 | 19K | -2.20% |
| 2026-01-29 | 4.37 | 4.55 | 4.10 | 4.10 | 24K | -7.45% |
| 2026-01-28 | 4.53 | 4.53 | 4.35 | 4.43 | 16K | -0.89% |
| 2026-01-27 | 4.38 | 4.64 | 4.34 | 4.47 | 42K | +3.00% |
| 2026-01-26 | 4.47 | 4.60 | 4.32 | 4.34 | 50K | -2.91% |
| 2026-01-24 | 4.23 | 4.60 | 4.17 | 4.47 | 73K | 0.00% |
| 2026-01-23 | 4.23 | 4.60 | 4.17 | 4.47 | 78K | +7.45% |
| 2026-01-22 | 4.08 | 4.40 | 3.98 | 4.16 | 95K | +1.96% |
| 2026-01-21 | 4.02 | 4.15 | 3.91 | 4.08 | 59K | +2.26% |
| 2026-01-20 | 4.10 | 4.17 | 3.87 | 3.99 | 233K | -0.25% |
| 2026-01-16 | 4.15 | 4.29 | 3.95 | 4.00 | 69K | -6.54% |
See CANF's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs CANF Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare CANF vs AGIO
See how CANF stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonFrequently Asked Questions
How has CANF stock performed recently?
CANF returned +169.9% over the past year, beating its 5-year annualized CAGR of -25.1%. The stock trades above its 200-day moving average, confirming the uptrend.
What is CANF's all-time high price?
Can-Fite BioPharma Ltd. reached $1419.00 on 2013-12-23. The 52-week high is $4.93. Current 1-year return of +169.9% places the stock closer to historical peaks.
Where can I download CANF historical price data?
This page provides CANF daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2012-2026, downloadable in CSV format.